Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia

1

Review clinical trials related to Subjects With Mild Cognitive Impairment (MCI) of AD, Alzheimer's Disease (AD) Dementia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluate the Use of [18F]-APN-1607 PET in Subjects With AD-related Cognitive Impairment and Subjects With Normal Cognitive Function

This study is to evaluate the efficacy and safety of \[18F\]-APN-1607 Injection in PET imaging for detecting AD-related cognitive impairment.

Participants needed: 316
Trial details
Phase: Phase 3Age: 50+Biological sex: AllType: InterventionalSponsor: JYAMS PET Research & Development LimitedUpdated: Feb 20, 2026Locations: 2
Eligibility criteria

Subjects must be able to understand and voluntarily sign a written informed cons... [+4]

Specific clinical phenotypes of atypical AD as defined in the 2014 IWG-2 criteri... [+12]